Stockscreener 앱 받기
10.04
19.81%
1.66
시간 외 거래:
9.60
-0.44
-4.38%
전일 마감가:
$8.38
열려 있는:
$8.66
하루 거래량:
336.83K
Relative Volume:
10.32
시가총액:
$40.62M
수익:
$147.75M
순이익/손실:
$-284.23M
주가수익비율:
-3.4266
EPS:
-2.93
순현금흐름:
$-317.54M
1주 성능:
+20.10%
1개월 성능:
+15.54%
6개월 성능:
+52.18%
1년 성능:
+20.64%
1일 변동 폭
$8.6001
$10.45
1주일 범위
$8.37
$10.45
52주 변동 폭
$4.85
$21.94
Fibrogen Inc Stock (FGEN) Company Profile
명칭
Fibrogen Inc
전화
415-978-1200
주소
350 BAY STREET, SAN FRANCISCO, CA
FGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FGEN
Fibrogen Inc
|
10.04 | 33.90M | 147.75M | -284.23M | -317.54M | -2.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fibrogen Inc Stock (FGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-08-08 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-06-26 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-06-26 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-06-26 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-06-26 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-06-02 | 업그레이드 | Stifel | Hold → Buy |
| 2023-01-31 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2023-01-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-01-05 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-09-22 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-08-20 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2021-07-16 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-07-16 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-04-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2021-04-07 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2021-03-31 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-03-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-02-01 | 개시 | H.C. Wainwright | Buy |
| 2020-10-26 | 개시 | Raymond James | Underperform |
| 2020-07-10 | 재개 | Stifel | Buy |
| 2020-05-01 | 개시 | Cowen | Market Perform |
| 2020-04-27 | 개시 | BofA/Merrill | Neutral |
| 2019-05-29 | 재개 | Goldman | Neutral |
| 2019-05-10 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-04-12 | 개시 | Piper Jaffray | Neutral |
| 2019-02-11 | 재개 | Stifel | Buy |
| 2018-12-19 | 업그레이드 | Citigroup | Neutral → Buy |
| 2017-08-08 | 재확인 | Leerink Partners | Outperform |
| 2017-08-08 | 재확인 | Stifel | Buy |
| 2017-07-21 | 다운그레이드 | Goldman | Buy → Neutral |
| 2017-07-11 | 개시 | Jefferies | Buy |
| 2016-02-11 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2016-01-21 | 개시 | Credit Suisse | Neutral |
| 2015-12-04 | 개시 | Citigroup | Buy |
| 2015-09-23 | 개시 | Lake Street | Hold |
| 2015-07-29 | 개시 | Citigroup | Buy |
| 2015-07-20 | 업그레이드 | Goldman | Neutral → Buy |
| 2014-12-09 | 개시 | Stifel | Buy |
모두보기
Fibrogen Inc 주식(FGEN)의 최신 뉴스
FDA grants orphan drug designation to FibroGen’s roxadustat for MDS By Investing.com - Investing.com Nigeria
FDA grants orphan drug designation to FibroGen’s roxadustat for MDS - Investing.com India
FibroGen shares advance after roxadustat earns orphan drug status - MSN
FibroGen stock rises after roxadustat receives Orphan Drug Designation By Investing.com - Investing.com India
FibroGen stock rises after roxadustat receives Orphan Drug Designation - Investing.com
FibroGen (FGEN) Gains FDA Orphan Drug Status for Roxadustat - GuruFocus
Roxadustat granted orphan drug designation for the treatment of myelodysplastic syndromes by the U.S. FDA - marketscreener.com
FibroGen Receives FDA Orphan Drug Designation for Roxadustat in Myelodysplastic Syndromes, Phase 3 Protocol Set for Q4 2025 Submission - Quiver Quantitative
Roxadustat Granted Orphan Drug Designation for the - GlobeNewswire
Market Review: Will FibroGen Inc stock keep outperforming rivals2025 Risk Factors & Breakout Confirmation Trade Signals - moha.gov.vn
FibroGen Investor Suit Dismissed Following $28.5 Million Deal - Bloomberg Law News
Can FibroGen Inc. (1FG0) stock deliver strong annual returnsSell Signal & AI Powered Market Entry Strategies - Newser
Will FibroGen Inc. (1FG0) stock outperform global peers2025 Valuation Update & Safe Capital Growth Stock Tips - Newser
FibroGen (FGEN) Stock Analysis Report | Financials & Insights - Benzinga
Is FibroGen Inc. (1FG0) stock overpriced at current multiplesDividend Hike & Weekly Momentum Picks - Newser
How FibroGen Inc. (1FG0) stock reacts to fiscal policiesWeekly Trade Review & Weekly Watchlist for Hot Stocks - Newser
How dovish Fed policy supports FibroGen Inc. (1FG0) stockAnalyst Downgrade & Entry and Exit Point Strategies - Newser
How supply shortages influence FibroGen Inc. (1FG0) stockSell Signal & Weekly Return Optimization Alerts - Newser
Is FibroGen Inc. (1FG0) stock a top hedge fund pick2025 Fundamental Recap & Smart Allocation Stock Tips - Newser
FibroGen, Inc. to Present at Oppenheimer Movers in Rare Disease Summit on December 11, 2025 - Quiver Quantitative
FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit - GlobeNewswire
Will FibroGen Inc. stock outperform international peers2025 Fundamental Recap & AI Powered Buy and Sell Recommendations - moha.gov.vn
Why FibroGen Inc. (1FG0) stock is trending on social mediaJuly 2025 PreEarnings & AI Enhanced Execution Alerts - moha.gov.vn
FibroGen started at buy by H.C. Wainwright - MSN
What valuation multiples suggest for FibroGen Inc. stockWeekly Trade Analysis & Verified Momentum Watchlists - newser.com
Can FibroGen Inc. (1FG0) stock ride next bull market cycle2025 Pullback Review & Short-Term Trading Opportunity Alerts - newser.com
Why FibroGen Inc. stock remains resilientPortfolio Return Summary & Real-Time Buy Signal Alerts - newser.com
Can FibroGen Inc. (1FG0) stock deliver consistent EPS growthJuly 2025 Decliners & Weekly Top Gainers Alerts - newser.com
Is FibroGen Inc. stock vulnerable to regulatory risks2025 Bull vs Bear & AI Powered Buy and Sell Recommendations - newser.com
Can FibroGen Inc. (1FG0) stock resist broad market declines2025 Volatility Report & Intraday High Probability Alerts - newser.com
Will earnings trigger a reversal in FibroGen Inc.Trade Volume Summary & Reliable Volume Spike Trade Alerts - newser.com
What drives FibroGen Inc stock priceCandlestick Trading Patterns & Free Take Advantage Of Momentum - earlytimes.in
Chart based exit strategy for FibroGen Inc.July 2025 Summary & Daily Technical Forecast Reports - newser.com
What hedge fund activity signals for FibroGen Inc. stockWeekly Trading Summary & Daily Growth Stock Investment Tips - newser.com
Fibrogen Inc (FGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Fibrogen Inc 주식 (FGEN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Wettig Thane | CEO |
Nov 13 '25 |
Buy |
9.18 |
1,000 |
9,180 |
22,239 |
| Schoeneck James A | Director |
Jun 30 '25 |
Buy |
5.07 |
23,567 |
119,485 |
39,666 |
| Wettig Thane | CEO |
Mar 24 '25 |
Buy |
0.35 |
145,000 |
50,663 |
543,329 |
| Schoeneck James A | Director |
Mar 20 '25 |
Buy |
0.35 |
250,000 |
88,000 |
323,722 |
| Schoeneck James A | Director |
Mar 21 '25 |
Buy |
0.34 |
50,000 |
17,040 |
373,722 |
0.36%
1.05%
자본화:
|
볼륨(24시간):